Last Updated: June 25, 2026

Suppliers and packagers for atralin


✉ Email this page to a colleague

« Back to Dashboard


atralin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Dow Pharm ATRALIN tretinoin GEL;TOPICAL 022070 NDA Bausch Health US, LLC 13548-070-45 1 TUBE in 1 PACKAGE (13548-070-45) / 45 g in 1 TUBE 2007-07-26
Dow Pharm ATRALIN tretinoin GEL;TOPICAL 022070 NDA AUTHORIZED GENERIC Obagi Cosmeceuticals LLC 62032-413-20 20 g in 1 TUBE (62032-413-20) 2014-06-19
Dow Pharm ATRALIN tretinoin GEL;TOPICAL 022070 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-800-45 1 TUBE in 1 PACKAGE (68682-800-45) / 45 g in 1 TUBE 2007-07-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for ATRALIN (tretinoin) topical gel: What CDMOs and manufacturers make it, and who controls the supply chain

Last updated: June 6, 2026

ATRA LIN is a brand of tretinoin for acne, formulated as a topical drug product. Supplier coverage depends on whether you mean the branded finished dosage form supplied to FDA-registered distributors (finished-goods manufacturers) or the upstream suppliers of API and key excipients. Publicly citable supplier identities for ATRALIN are not provided in the request, so no complete, accurate supplier roster can be produced.

What companies supply ATRALIN to the US market?

No supplier list is provided in the input, and there is not enough information to identify ATRALIN’s finished-goods manufacturers, label holders, or distribution partners with citable specificity.

What is the ATRALIN API supplier landscape for tretinoin?

No API supplier identifiers for tretinoin used specifically for ATRALIN are supplied in the request. A complete and accurate ATRALIN-linked API supplier map cannot be generated from the provided information.

Which manufacturers produce ATRALIN topical gel dosage forms?

ATRA LIN is a topical tretinoin product, but no strength, package form, NDA/ANDA reference, or FDA establishment linkage is supplied. Without those identifiers, it is not possible to compile the correct manufacturer-of-record list.

What do FDA labels and registration data say about ATRALIN manufacturers?

No NDA label, FDA drug product listing identifiers, or SPL package details are included. Without those inputs, a correct Orange Book and FDA establishment crosswalk cannot be built.

How do upstream excipient suppliers affect ATRALIN supply continuity?

No formulation composition, supplier-of-record, or grade specifications for excipients are included. A supplier risk profile for ATRALIN excipients cannot be produced from the request alone.

Who controls ATRALIN contract manufacturing (CDMOs) and private-label production?

No ATRALIN manufacturing/contracting disclosure is provided, so CDMO participation cannot be identified accurately.

What generic or private-label tretinoin equivalents compete with ATRALIN, and who makes them?

No comparator products, strengths, or referenced ANDAs are provided. A competitive supplier map cannot be produced.

Key Takeaways

  • ATRALIN is a topical tretinoin acne product, but the request does not include FDA identifiers (NDA/labeler/manufacturer) needed to produce a reliable supplier list.
  • A complete, citable roster of finished-goods manufacturers, API suppliers, CDMOs, and excipient sources cannot be generated from the information given.

FAQs

  1. How can I identify who manufactures a specific ATRALIN strength and package?
  2. What FDA databases list finished-goods manufacturers for topical tretinoin?
  3. Do ATRALIN supplier changes show up in SPL or drug listing updates?
  4. Which tretinoin APIs are commonly sourced for topical acne products in the US?
  5. How do contract manufacturing arrangements typically appear on drug labels for topical generics?

References

  1. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
  2. FDA. Drugs@FDA.
  3. FDA. DailyMed.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.